Following recent transactions and cost-cutting efforts, Sol-Gel’s cash runway is expected to extend into the first quarter of 2026 Ongoing Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with ...
Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least double the drug’s commercial potentialIn September 2025 ...
LONDON--(BUSINESS WIRE)--The global sol-gel coatings market is expected to grow by USD 2.63 billion during 2020-2024. The report also provides the market impact and new opportunities created due to ...
Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...
Sol-Gel Technologies ( ($SLGL) ) just unveiled an announcement. On November 20, 2025, Sol-Gel Technologies announced its financial results for the ...
Reports Q3 revenue $400k vs $5.4M last year. Mori Arkin, Executive Chairman of Sol-Gel, stated: “Sol-Gel continued to make steady progress in the ...
NESS ZIONA, Israel & LAUSANNE, Switzerland--(BUSINESS WIRE)--Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology ...
New sol-gel inks can be printed into patterns to produce 3-D structures of metal oxides with nanoscale features. The ability to directly pattern functional oxides at the nanoscale opens a new avenue ...
SLGL is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of SLGL shares has increased $0.30 since the market last closed. This is a 0.76% ...
The following language describes the imported merchandise from China: The merchandise covered by this investigation is sol gel alumina-based ceramic abrasive grains which are comprised of minimum 94% ...
Total revenue in the third quarter was $5.4 million which primarily consisted of licensing revenue from Padagis, Galderma, Searchlight and seven new license agreements, compared to $0.2 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback